These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7342648)

  • 1. Hageman factor (factor XII) in health and diseases.
    Saito H
    Nihon Ketsueki Gakkai Zasshi; 1981 Dec; 44(7):1460-5. PubMed ID: 7342648
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between kallikrein release and factor XII in normal persons and carriers of the Hageman trait.
    Torres M; Ercoreca L; Lucia JF; Giralt M; Raichs A
    Thromb Haemost; 1979 Dec; 42(4):1286-8. PubMed ID: 261563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma factor XII (Hageman factor) in disease states (author's transl)].
    Ichinose A; Maruyama I; Imaguma M; Sonoda T; Igata A
    Rinsho Ketsueki; 1981 Aug; 22(8):1232-6. PubMed ID: 7328776
    [No Abstract]   [Full Text] [Related]  

  • 4. [Factor XII deficiency - Hageman trait. Additional diagnostic procedures].
    Martinić P
    Bilt Hematol Transfuz; 1979; 7(2-3):151-8. PubMed ID: 263755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction].
    Halbmayer WM; Mannhalter C; Feichtinger C; Rubi K; Fischer M
    Wien Med Wochenschr; 1993; 143(2):43-50. PubMed ID: 8488686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factor XII (Hageman factor)].
    Saito H
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():657-9. PubMed ID: 15658416
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of factor XII and plasma prekallikrein with chromozym PK].
    Stürzebecher J; Klessen C; Markwardt F
    Z Med Lab Diagn; 1982 Oct; 23(5):306-11. PubMed ID: 6924817
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluid phase activation of Hageman factor (factor XII) in citrated human plasma by bromelain: an application to the indirect enzymatic assay for Hageman factor.
    Oh-ishi S
    Thromb Res; 1982 Sep; 27(5):619-23. PubMed ID: 6983741
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular heterogeneity of Hageman trait (factor XII deficiency): evidence that two of 49 subjects are cross-reacting material positive (CRM+).
    Saito H; Scott JG; Movat HZ; Scialla SJ
    J Lab Clin Med; 1979 Aug; 94(2):256-65. PubMed ID: 110893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inheritance pattern of factor XII (Hageman) deficiency in domestic cats.
    Kier AB; Bresnahan JF; White FJ; Wagner JE
    Can J Comp Med; 1980 Jul; 44(3):309-14. PubMed ID: 7427778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of factor XII analysis in blood coagulation tests].
    Saito H
    Nihon Rinsho; 1989 Dec; 48 Suppl():843-5. PubMed ID: 2622016
    [No Abstract]   [Full Text] [Related]  

  • 12. Hageman factor deficiency presentation and implications for management.
    Harper K; Friedland ML
    Conn Med; 1992 Sep; 56(9):469-71. PubMed ID: 1424610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factor XII deficiency - Hageman trait. Report of 2 cases].
    Martinić P; Dubravcić M; Vucenik I
    Bilt Hematol Transfuz; 1978; 6(1):29-34. PubMed ID: 755480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classic gout in Hageman factor (Factor XII) deficiency.
    Green D; Arsever CL; Grumet KA; Ratnoff OD
    Arch Intern Med; 1982 Aug; 142(8):1556-7. PubMed ID: 7103639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XII (Hageman Factor) Deficiency: a rare harbinger of life threatening complications.
    Chaudhry LA; El-Sadek WYM; Chaudhry GA; Al-Atawi FE
    Pan Afr Med J; 2019; 33():39. PubMed ID: 31384354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patients.
    Levi M; Hack CE; de Boer JP; Brandjes DP; Büller HR; ten Cate JW
    Agents Actions Suppl; 1992; 38 ( Pt 2)():292-8. PubMed ID: 1462834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why do we want to know how factor XII levels are modulated?
    Schmaier AH
    Thromb Res; 2010 Feb; 125(2):105-6. PubMed ID: 19850327
    [No Abstract]   [Full Text] [Related]  

  • 18. Factor XII (Hageman) levels in women with recurrent pregnancy loss.
    Ozgu-Erdinc AS; Togrul C; Aktulay A; Buyukkagnici U; Yapar Eyi EG; Erkaya S
    J Pregnancy; 2014; 2014():459192. PubMed ID: 25436153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should factor XII assays be included in thrombophilia screening?
    Winter M; Gallimore M; Jones DW
    Lancet; 1995 Jul; 346(8966):52. PubMed ID: 7603161
    [No Abstract]   [Full Text] [Related]  

  • 20. Improved methods to assay contact activation.
    Soulier JP; Gozin D
    Adv Biosci; 1978 Jul; 17():271-80. PubMed ID: 755703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.